PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC5446464::ACT049638

LRIPVA

Evidence text

Paper-level observation

Table 3: Spinach rubisco, LRIPVA, 100 mg/kg, 0 mmHg reduction.
tableConfidence: medium

Assay observation

Activity
Metabolic/Cardiovascular
Subtype
ACE Inhibitor
Measure
survival_rate
Comparator
=
Raw observation
0 mmHg
Normalized measurement
=0 other
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Rattus norvegicus
Assay method
Not reported by source
Sequence
LRIPVA
Standardization
ready simple
Assay conditions
"original_unit=mmHg"

Source publication

STRUCTURAL CHARACTERISTICS AND ANTIHYPERTENSIVE EFFECTS OF ANGIOTENSIN-I-CONVERTING ENZYME INHIBITORY PEPTIDES IN THE RENIN-ANGIOTENSIN AND KALLIKREIN KININ SYSTEMS.

African Journal of Traditional, Complementary, and Alternative Medicines · 2017

DOI 10.21010/ajtcam.v14i2.39 PMC5446464
Parent mention Integrated peptide

Related peptide identities

PEPDIA-PLP-003857PEPDIA-INT-025875

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.